Addex Therapeutics (ADXN) Institutional Ownership $8.11 -0.90 (-9.99%) As of 10:22 AM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Addex Therapeutics (NASDAQ:ADXN)CurrentInstitutional OwnershipPercentage16.14%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$141.41KNumber ofInstitutional Sellers(last 12 months)0 Get ADXN Insider Trade Alerts Want to know when executives and insiders are buying or selling Addex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADXN Institutional Buying and Selling by Quarter Addex Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/7/2025 GAMMA Investing LLC8,757$64K0.0%+766.2%0.826% 2/17/2025 Citadel Advisors LLC12,079$85K0.0%N/A1.140% 2/13/2024 Armistice Capital LLC43,000$260K0.0%-92.0%4.343% 11/15/2023 Armistice Capital LLC537,000$206K0.0%+103.4%65.328% 5/1/2023 Virtu Financial LLC42,912$41K0.0%+203.8%0.334% 2/14/2023 Susquehanna International Group LLP72,142$45K0.0%N/A0.561% 2/10/2023 NEA Management Company LLC1,080,000$113K0.0%-80.9%8.398% 11/14/2022 Armistice Capital LLC320,000$256K0.0%+26.5%2.941% 11/14/2022 NEA Management Company LLC5,648,690$830K0.0%+500.0%51.923% 8/5/2022 OLD Mission Capital LLC31,134$36K0.0%N/A0.286% 8/12/2021 New Leaf Venture Partners L.L.C.50,000$478K0.1%N/A0.609% 8/2/2021 NEA Management Company LLC180,000$17.21M0.2%N/A2.192% 5/21/2021 Citadel Advisors LLC11,604$121K0.0%N/A0.141% 5/18/2021 Citadel Advisors LLC11,604$121K0.0%N/A0.212% 5/12/2021 UBS Group AG2,520$26K0.0%+2,420.0%0.046% (Data available from 1/1/2016 forward) ADXN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADXN shares? During the previous two years, the following institutional investors and hedge funds held shares of Addex Therapeutics shares: Armistice Capital LLC ($260K), and Citadel Advisors LLC ($85K), GAMMA Investing LLC ($64K).Learn more on ADXN's institutional investors. What percentage of Addex Therapeutics stock is owned by institutional investors? 16.14% of Addex Therapeutics stock is owned by institutional investors. Learn more on ADXN's institutional investor holdings. Which institutional investors have been buying Addex Therapeutics stock? The following institutional investors have purchased Addex Therapeutics stock in the last 24 months: Armistice Capital LLC ($273K), Citadel Advisors LLC ($12.08K), and GAMMA Investing LLC ($7.75K). How much institutional buying is happening at Addex Therapeutics? Institutional investors have bought a total of 292,825 shares in the last 24 months. This purchase volume represents approximately $2.24M in transactions. Which Addex Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Addex Therapeutics stock in the last 24 months: Armistice Capital LLC ($494K). How much institutional selling is happening at Addex Therapeutics? Institutional investors have sold a total of 494,000 shares in the last 24 months. This volume of shares sold represents approximately $2.99M in transactions. Related Companies Aligos Therapeutics Major Shareholders Rani Therapeutics Major Shareholders Pulmatrix Major Shareholders Dyadic International Major Shareholders Kezar Life Sciences Major Shareholders Marinus Pharmaceuticals Major Shareholders ALX Oncology Major Shareholders BioAtla Major Shareholders Allakos Major Shareholders FibroGen Major Shareholders This page (NASDAQ:ADXN) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.